Goldman Sachs Group Inc Sc Pharmaceuticals Inc. Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
A detailed history of Goldman Sachs Group Inc transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 101,888 shares of SCPH stock, worth $577,704. This represents 0.0% of its overall portfolio holdings.
Number of Shares
101,888
Previous 120,897
15.72%
Holding current value
$577,704
Previous $317,000
22.4%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding SCPH
# of Institutions
101Shares Held
36.5MCall Options Held
757KPut Options Held
0-
Orbimed Advisors LLC San Diego, CA6.06MShares$34.4 Million0.82% of portfolio
-
Rubric Capital Management LP New York, NY4.6MShares$26.1 Million0.4% of portfolio
-
Aigh Capital Management LLC Baltimore, MD3.87MShares$21.9 Million8.33% of portfolio
-
King Luther Capital Management Corp Fort Worth, TX3.54MShares$20.1 Million0.06% of portfolio
-
Morgan Stanley New York, NY2.15MShares$12.2 Million0.0% of portfolio
About scPharmaceuticals Inc.
- Ticker SCPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,402,100
- Market Cap $155M
- Description
- scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...